Samrat Pharmachem Limited (BOM:530125)

Samrat Pharmachem Revenue

Samrat Pharmachem had revenue of 797.61M INR in the quarter ending June 30, 2026, with 5.43% growth. This brings the company's revenue in the last twelve months to 2.94B, up 4.68% year-over-year. In the fiscal year ending March 31, 2026, Samrat Pharmachem had annual revenue of 2.90B with 1.35% growth.

• Revenue (ttm): 2.94B
• Revenue Growth: +4.68%
• P/S Ratio: 0.24
• Revenue / Employee: 97.94M
• Employees: 30
• Market Cap: 701.83M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.90B	38.61M	1.35%
Mar 31, 2025	2.86B	42.90M	1.52%
Mar 31, 2024	2.82B	-291.06M	-9.37%
Mar 31, 2023	3.11B	888.86M	40.06%
Mar 31, 2022	2.22B	426.92M	23.83%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error